Ngai Chiu Tse
Net worth: 638 550 $ as of 2026-08-30
Net worth: 638 550 $ as of 2026-08-30
Ngai Chiu Tse is currently an Assistant Professor at Weill Cornell Medical College and the Head of Research & Development at Adlai Nortye Ltd. He previously worked as an Assistant Member at Memorial Sloan Kettering Cancer Center and as the Chief Scientific Officer & Senior Vice President at CStone Pharmaceuticals Co. Ltd. Tse obtained his doctorate degrees from the University of Southern California in 2002.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-17 | 150,000 ( 0.16% ) | 638 550 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| ADLAI NORTYE GROUP LTD. | Chief Tech/Sci/R&D Officer | 2024-03-28 |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Corporate Officer/Principal | - |
| CSTONE PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Operates as a nonprofit cancer hospital | Health Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
Adlai Nortye Ltd.
Adlai Nortye Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biopharmaceuticals for cancer immunotherapy | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions